semaglutide .75 mg FDA approves obesity drug that helped people cut weight 15% where it is used as energy Wegovy: Package Insert / Prescribing

doi: 10.1002/pros.24131 120 TricoliJVWinterDLHanlonALRaysorSLWatkins-BrunerDPinoverWHet al

The Lancet Haematology

Eating slowly and stopping before fullness Eating slowly and stopping before fullness matters more on GLP-1 medications than it does normally

In fact, research published in Diabetes, Obesity, and Metabolism found that participants regained two-thirds of the weight they had previously lost after they stopped using Wegovy

The ad will launch the brand's "Healthier on Ro" campaign

Cheaper obesity medications could come to Canada this summer, as Health Canada reviews generics Canadian company seeks to stand out with domestically-made generic Ozempic While it's not clear exactly when generic versions of these drugs will be available in Canada, patients and doctors are eagerly anticipating that moment, because it means the medications will become more cost effective and accessible to those who need them